Detailed financial statements for Coeptis Therapeutics Holdings, Inc. (COEP): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year with up to 20 years of history.
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology.
Analysis Summary
Coeptis Therapeutics Holdings, Inc. reported revenue of $1.4M in the most recent fiscal year, growing at a 5-year CAGR of 113.5%.
Trailing-twelve-month margins: gross margin 86.7%, operating margin -9.6%, net margin -8.7%.
At the current price of $10.99, COEP has negative trailing earnings (P/E not meaningful) and an ROE of -69.09%. Market capitalisation stands at $39M.
Balance sheet quality for COEP: current ratio of 4.2, net cash position of $6.1M. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Income Statement (10y)
| Year | 2004 | 2005 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Revenue | 0 | 0 | 0 | 0 | $30761 | $75000 | 0 | 0 | 0 | $1.4M |
| Cost of Revenue | 0 | 0 | 0 | 0 | $964217 | 0 | 0 | 0 | 0 | $180625 |
| Gross Profit | 0 | 0 | 0 | 0 | -$933456 | $75000 | 0 | 0 | 0 | $1.2M |
| Research & Development | 0 | 0 | 0 | 0 | $3543 | 0 | $20887 | $6.7M | $2.3M | $1.3M |
| Selling, General & Admin | $10077 | $308305 | 0 | 0 | $5.8M | $14.1M | $34.2M | $13.8M | $6.7M | $11.9M |
| Operating Expenses | $10077 | $308305 | 0 | 0 | $5.9M | $14.1M | $34.2M | $21.5M | $10.1M | $14.2M |
| Operating Income | -$10077 | -$308000 | 0 | 0 | -$6.9M | -$14.0M | -$34.2M | -$21.5M | -$10.1M | -$13.0M |
| EBITDA | $2.6M | -$308000 | -$7070 | $171860 | -$8.7M | -$12.8M | -$36.4M | -$20.1M | -$9.4M | -$10.4M |
| Interest Expense | 0 | 0 | 0 | 0 | $148192 | $187133 | $218412 | $107685 | $396116 | $642379 |
| Pre-tax Income | $2.6M | 0 | -$7073 | -$2234 | -$9.2M | -$13.4M | -$37.6M | -$21.3M | -$10.9M | -$12.3M |
| Income Tax | 0 | $36000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | $2.6M | -$344000 | -$7073 | -$2234 | -$9.2M | -$13.4M | -$37.6M | -$21.3M | -$10.7M | -$11.9M |
| EPS | $1421.16 | $-184.81 | $-0.01 | $-0.00 | $-0.45 | $-13.16 | $-2.87 | $-0.83 | $-5.65 | $-2.81 |
| EPS (Diluted) | $1421.16 | $-184.81 | $-0.01 | $-0.00 | $-0.45 | $-13.16 | $-2.87 | $-0.83 | $-5.65 | $-2.81 |
| Shares Outstanding (Diluted) | $1863 | $1863 | $539062 | $10.8M | $20.4M | $1.0M | $14.3M | $25.7M | $1.9M | $4.2M |
Income Statement (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Revenue | $237441 | $862049 | $113771 | $1.6M |
| Gross Profit | $192286 | $816892 | $68615 | -$608438 |
| Operating Income | -$2.5M | -$2.0M | -$3.9M | -$13.8M |
| EBITDA | -$2.5M | -$876404 | -$3.5M | -$13.8M |
| Net Income | -$2.7M | -$1.6M | -$4.0M | -$13.7M |
| EPS | $-0.58 | $-0.29 | $-0.65 | $-0.28 |
| EPS (Diluted) | $-0.58 | $-0.29 | $-0.65 | $-0.28 |
Balance Sheet (10y)
| Year | 2004 | 2005 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Cash & Equivalents | $383 | $153558 | 0 | $505 | $202965 | $2.2M | $3.8M | $1.5M | $532885 | $5.7M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $676596 |
| Receivables | 0 | 0 | 0 | 0 | $21786 | 0 | $8075 | $38978 | 0 | $7348 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $383 | $153558 | 0 | $505 | $224751 | $2.2M | $3.9M | $1.7M | $1.1M | $7.4M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | $73732 | $31851 | $71456 | $108877 | $59783 | $18399 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $46538 | 0 | 0 | 0 | 0 | $4.6M | $3.6M | $2.6M | $541875 | $361250 |
| Total Assets | $46921 | $153558 | $80000 | $171545 | $300484 | $6.8M | $7.9M | $8.1M | $8.9M | $19.8M |
| Accounts Payable | $215935 | $55215 | 0 | $450 | $1.6M | $134092 | $99021 | $1.4M | $1.3M | $888755 |
| Short-term Debt | $95000 | $650000 | $62073 | $152644 | $1.9M | $2.4M | $1.9M | $1.0M | $1.2M | $118875 |
| Total Current Liabilities | $310935 | $705215 | $62073 | $155852 | $5.3M | $2.8M | $2.2M | $3.0M | $4.5M | $1.8M |
| Long-term Debt | 0 | 0 | 0 | 0 | $150000 | $1.6M | $150000 | $150000 | $150000 | $150000 |
| Total Liabilities | $310935 | $705215 | $62073 | $155852 | $5.4M | $4.4M | $3.5M | $3.8M | $5.0M | $2.1M |
| Retained Earnings | -$2.9M | -$3.3M | -$7073 | -$9307 | -$14.1M | -$27.6M | -$66.1M | -$87.4M | -$98.2M | -$110.0M |
| Total Equity | -$264014 | -$551657 | $17927 | $15692 | -$5.1M | $2.4M | $4.5M | $4.3M | $3.2M | $17.2M |
| Total Debt | $95000 | $650000 | $62073 | $152644 | $2.1M | $4.1M | $2.1M | $1.2M | $1.4M | $268875 |
| Net Debt | $94617 | $496442 | $62073 | $152139 | $1.9M | $1.9M | -$1.7M | -$244908 | $866168 | -$6.1M |
| Working Capital | -$310552 | -$551657 | -$62073 | -$155347 | -$5.1M | -$585384 | $1.8M | -$1.2M | -$3.5M | $5.6M |
Balance Sheet (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Cash & Equivalents | $4.9M | $5.7M | $5.2M | $15.5M |
| Total Assets | $16.3M | $19.8M | $19.8M | $134.5M |
| Total Liabilities | $3.3M | $2.1M | $2.2M | $2.0M |
| Total Equity | $12.5M | $17.2M | $20.8M | $132.5M |
| Total Debt | $279865 | $268875 | $343353 | 0 |
Cash Flow (10y)
| Year | 2004 | 2005 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Net Income | $2.6M | -$344305 | -$2234 | -$9.2M | -$13.4M | -$37.6M | -$21.3M | -$10.9M | -$11.9M |
| Depreciation & Amortization | 0 | 0 | 0 | $323428 | $447413 | $1.0M | $1.0M | $1.0M | $1.2M |
| Stock-based Compensation | 0 | 0 | 0 | 0 | $1.9M | 0 | $477503 | $1.1M | $1.2M |
| Change in Working Capital | -$1.1M | -$72720 | $450 | $2.7M | -$3.0M | -$550335 | $1.7M | -$125262 | -$1.5M |
| Operating Cash Flow | $1.6M | -$417025 | -$90066 | -$3.1M | -$4.5M | -$3.9M | -$7.2M | -$6.6M | -$8.6M |
| Capital Expenditure | 0 | 0 | 0 | 0 | -$1.8M | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | -$247165 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | $1.6M | -$417025 | -$90066 | -$3.1M | -$6.2M | -$3.9M | -$7.2M | -$6.6M | -$8.6M |
Cash Flow (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Operating Cash Flow | -$2.2M | -$1.7M | -$1.8M | $1.6M |
| Capital Expenditure | -$3 | 0 | -$3 | 0 |
| Free Cash Flow | -$2.2M | -$1.7M | -$1.8M | $1.6M |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Stock-based Compensation | 0 | $213905 | $1.4M | $5.6M |
Growth & Margins (10y)
| Year | 2004 | 2005 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Revenue Growth (YoY) | | | | | | +143.8% | -100.0% | | | |
| Net Income Growth (YoY) | | -113.0% | +97.9% | +68.4% | -409760.6% | -46.9% | -179.4% | +43.4% | +49.8% | -11.6% |
| EPS Growth (YoY) | | -113.0% | +100.0% | +98.5% | -224900.0% | -2824.4% | +78.2% | +71.1% | -580.7% | +50.3% |
| Shares Change (YoY) | | +0.0% | +28835.2% | +1900.0% | +89.6% | -95.0% | +1298.8% | +79.7% | -92.5% | +120.0% |
| FCF Growth (YoY) | | -126.8% | +78.4% | -3382.0% | -99.0% | +37.9% | -86.8% | +8.2% | -29.4% |
| Gross Margin | | | | | -3034.5% | 100.0% | | | | 86.7% |
| Operating Margin | | | | | -22305.5% | -18727.9% | | | | -956.9% |
| EBITDA Margin | | | | | -28232.7% | -17086.3% | | | | -763.9% |
| Net Margin | | | | | -29765.9% | -17932.4% | | | | -874.3% |
| FCF Margin | | | | -10195.1% | -8319.3% | | | | -631.2% |
| Effective Tax Rate | 0.0% | | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Per-Share Data (10y)
| Year | 2004 | 2005 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF Per Share | $834.05 | $-0.77 | $-0.01 | $-0.15 | $-6.11 | $-0.27 | $-0.28 | $-3.45 | $-2.03 |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | $1863 | $1863 | $539062 | $10.8M | $20.4M | $1.0M | $14.3M | $25.7M | $1.9M | $4.2M |
What to look at in Technology companies
- Revenue growth 3y (>=15%/year) — Validates sustained traction, not a one-off.
- Gross margin (Sub-sector dependent) — SaaS >=70%, Internet >=55%, Semis >=45%, Hardware >=35%.
- FCF / Revenue (>=20%) — Real cash generated. Many tech firms dress up non-GAAP earnings.
- ROIC (>=15%) — Capital reinvested efficiency — Buffett's first metric.
- SBC / Revenue (<10% healthy) — Stock-based compensation. Silent dilution: >20% destroys value.
- Net Debt / EBITDA (<=2x (1.5x SaaS)) — Resilience in downturns and rate hikes.
Profitability
| Return on Equity | -69.09% |
| Return on Invested Capital | -71.70% |
| Return on Assets | -60.06% |
| Gross Margin | 86.75% |
| Operating Margin | -956.94% |
| Net Margin | -874.29% |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 4.16 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 7.84 |
Key Ratios (10y)
| Year | 2004 | 2005 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | 0.14 | -1.07 | -15000.00 | -990000.00 | -452.89 | -15.20 | -10.67 | -18.89 | -0.97 | -5.07 |
| P/B | -1.40 | -0.67 | 5953.83 | 136036.67 | -809.96 | 86.96 | 98.30 | 93.38 | 3.32 | 3.50 |
| P/S | 0.00 | 0.00 | 0.00 | 0.00 | 135427.19 | 2725.33 | 0.00 | 0.00 | 0.00 | 44.27 |
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | -3034.5% | 100.0% | 0.0% | 0.0% | 0.0% | 86.7% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | -22305.5% | -18727.9% | 0.0% | 0.0% | 0.0% | -956.9% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | -29765.9% | -17932.4% | 0.0% | 0.0% | 0.0% | -874.3% |